The Discounted Cash Flow (DCF) valuation of Transgene Biotek Ltd (526139.BO) is (2.80) INR. With the latest stock price at 4.85 INR, the upside of Transgene Biotek Ltd based on DCF is -157.7%.
Based on the latest price of 4.85 INR and our DCF valuation, Transgene Biotek Ltd (526139.BO) is a sell. selling 526139.BO stocks now will result in a potential gain of 157.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 11.1% | 8.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (3.97) - (2.53) | (2.80) |
| Upside | -181.9% - -152.2% | -157.7% |